136 related articles for article (PubMed ID: 16027801)
1. Low daily dose of antioxidant probucol decreases incidence and severity of restenosis after transluminal coronary balloon angioplasty.
Kaminnyi AI; Lankin VZ; Samko AN; Sozykin AL; Provatorov SI; Konovalova GG; Perepelitsa EI; Tikhaze AK; Polevaya TY; Kukharchuk VV; Belenkov YN
Bull Exp Biol Med; 2005 Feb; 139(2):183-5. PubMed ID: 16027801
[TBL] [Abstract][Full Text] [Related]
2. Prevention of restenosis with antioxidants: mechanisms and implications.
Tardif JC; Grégoire J; L'Allier PL
Am J Cardiovasc Drugs; 2002; 2(5):323-34. PubMed ID: 14727962
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial.
Yokoi H; Daida H; Kuwabara Y; Nishikawa H; Takatsu F; Tomihara H; Nakata Y; Kutsumi Y; Ohshima S; Nishiyama S; Seki A; Kato K; Nishimura S; Kanoh T; Yamaguchi H
J Am Coll Cardiol; 1997 Oct; 30(4):855-62. PubMed ID: 9316509
[TBL] [Abstract][Full Text] [Related]
4. Relationship between free-radical lipid oxidation and efficiency of coronary angioplasty in coronary patients.
Kaminnyi AI; Lankin VZ; Perepelitsa EI; Konovalova GG; Samko AN; Tikhaze AK; Kukharchuk VV; Belenkov YN
Bull Exp Biol Med; 2007 Nov; 144(5):664-6. PubMed ID: 18683490
[TBL] [Abstract][Full Text] [Related]
5. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group.
Tardif JC; Cöté G; Lespérance J; Bourassa M; Lambert J; Doucet S; Bilodeau L; Nattel S; de Guise P
N Engl J Med; 1997 Aug; 337(6):365-72. PubMed ID: 9241125
[TBL] [Abstract][Full Text] [Related]
6. Impact of residual plaque burden after balloon angioplasty in the MultiVitamins and Probucol (MVP) trial.
Tardif JC; Côté G; Lespérance J; Gosselin G; Joyal M; de Guise P; Bilodeau L; Doucet S; Harel F; Couturier A; Gallo R; Grégoire J
Can J Cardiol; 2001 Jan; 17(1):49-55. PubMed ID: 11173314
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic prevention of both restenosis and atherosclerosis progression: AGI-1067, probucol, statins, folic acid and other therapies.
Tardif JC; Grégoire J; Lavoie MA; L'Allier PL
Curr Opin Lipidol; 2003 Dec; 14(6):615-20. PubMed ID: 14624139
[TBL] [Abstract][Full Text] [Related]
8. Effects of AGI-1067 and probucol after percutaneous coronary interventions.
Tardif JC; Grégoire J; Schwartz L; Title L; Laramée L; Reeves F; Lespérance J; Bourassa MG; L'Allier PL; Glass M; Lambert J; Guertin MC;
Circulation; 2003 Feb; 107(4):552-8. PubMed ID: 12566365
[TBL] [Abstract][Full Text] [Related]
9. Prevention of restenosis after angioplasty in small coronary arteries with probucol.
Rodés J; Côté G; Lespérance J; Bourassa MG; Doucet S; Bilodeau L; Bertrand OF; Harel F; Gallo R; Tardif JC
Circulation; 1998 Feb; 97(5):429-36. PubMed ID: 9490236
[TBL] [Abstract][Full Text] [Related]
10. Probucol decreases neointimal formation in a swine model of coronary artery balloon injury. A possible role for antioxidants in restenosis.
Schneider JE; Berk BC; Gravanis MB; Santoian EC; Cipolla GD; Tarazona N; Lassegue B; King SB
Circulation; 1993 Aug; 88(2):628-37. PubMed ID: 8339427
[TBL] [Abstract][Full Text] [Related]
11. Preventive effects of probucol on restenosis after percutaneous transluminal coronary angioplasty.
Watanabe K; Sekiya M; Ikeda S; Miyagawa M; Hashida K
Am Heart J; 1996 Jul; 132(1 Pt 1):23-9. PubMed ID: 8701872
[TBL] [Abstract][Full Text] [Related]
12. Heart disease. Keeping arteries open after angioplasty.
Harv Health Lett; 1997 Dec; 23(2):3-4. PubMed ID: 15344252
[No Abstract] [Full Text] [Related]
13. Antioxidants: the good, the bad and the ugly.
Tardif JC
Can J Cardiol; 2006 Feb; 22 Suppl B(Suppl B):61B-65B. PubMed ID: 16498514
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of probucol in preventing restenosis after percutaneous transluminal coronary angioplasty.
Lee YJ; Daida H; Yokoi H; Miyano H; Takaya J; Sakurai H; Mokuno H; Yamaguchi H
Jpn Heart J; 1996 May; 37(3):327-32. PubMed ID: 8774625
[TBL] [Abstract][Full Text] [Related]
15. Role of probucol in inhibiting intimal hyperplasia after coronary stent implantation: a randomized study.
Nunes GL; Abizaid AC; Theodoro MP; Brito FS; Caixeta A; da Silva LF; Mazzotti NG; Belló-Klein A; Clausell N
Am Heart J; 2006 Nov; 152(5):914.e1-7. PubMed ID: 17070157
[TBL] [Abstract][Full Text] [Related]
16. Clinical results with AGI-1067: a novel antioxidant vascular protectant.
Tardif JC
Am J Cardiol; 2003 Feb; 91(3A):41A-49A. PubMed ID: 12645643
[TBL] [Abstract][Full Text] [Related]
17. Effect of probucol on repeat revascularization rate after percutaneous transluminal coronary angioplasty (from the Probucol Angioplasty Restenosis Trial [PART]).
Daida H; Kuwabara Y; Yokoi H; Nishikawa H; Takatsu F; Nakata Y; Kutsumi Y; Oshima S; Nishiyama S; Ishiwata S; Kato K; Nishimura S; Miyauchi K; Kanoh T; Yamaguchi H
Am J Cardiol; 2000 Sep; 86(5):550-2, A9. PubMed ID: 11009277
[TBL] [Abstract][Full Text] [Related]
18. Effect of antioxidant probucol for preventing stent restenosis.
Kim MH; Cha KS; Han JY; Kim HJ; Kim JS
Catheter Cardiovasc Interv; 2002 Dec; 57(4):424-8. PubMed ID: 12455074
[TBL] [Abstract][Full Text] [Related]
19. Probucol mediates vascular remodeling after percutaneous transluminal angioplasty via down-regulation of the ERK1/2 signaling pathway.
Yang YB; Yang YX; Su B; Tang YL; Zhu BY; Hu ZW; Li GY; Li YJ; Liao DF
Eur J Pharmacol; 2007 Sep; 570(1-3):125-34. PubMed ID: 17628533
[TBL] [Abstract][Full Text] [Related]
20. Antioxidants decreases the intensification of low density lipoprotein in vivo peroxidation during therapy with statins.
Lankin VZ; Tikhaze AK; Kukharchuk VV; Konovalova GG; Pisarenko OI; Kaminnyi AI; Shumaev KB; Belenkov YN
Mol Cell Biochem; 2003 Jul; 249(1-2):129-40. PubMed ID: 12956408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
